• The EU and members states must recognise that antimicrobial resistance is a major European and global problem |
• Pharmaceutical companies should be encouraged to develop new antimicrobial agents but these will not solve the problem in the near future |
• The EU and member states should set up a European surveillance system of antimicrobial resistance |
• The EU and member states need to collect data on the supply and consumption of antimicrobial agents |
• The EU and member states should encourage the adoption of a wide range of measures to promote prudent use of antimicrobial agents |
• The EU and member states and national research councils should make coordinated research on antimicrobial resistance a high priority |
• A way should be found to review progress with these recommendations and proposals |